title: End-stage renal disease in 2010: Innovative approaches to improve outcomes in transplantation.
abstract: Renal transplantation offers the potential for improved quality and length of life to patients with end-stage renal disease; however, graft rejection and immunosuppression-related toxicities can hamper the effectiveness of this therapy. Seminal publications from 2010 have addressed these obstacles, and provide insight into new and innovative approaches to improve outcomes in renal transplant recipients.
authors.affiliation: Thomas E. Starzl Transplantation Institute, UPMC Montefiore 7S, 3459 5th Avenue, Pittsburgh, PA 15213, USA. shapiror@upmc.edu
authors.forename: Ron
authors.initials: R
authors.lastname: Shapiro
mesh_terms: D006084:Graft Rejection / Q000188:drug therapy* / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007676:Kidney Failure, Chronic / Q000601:surgery*; D016030:Kidney Transplantation; D016896:Treatment Outcome
chemical_list: D007166:Immunosuppressive Agents